Literature DB >> 16536220

Mosaicplasty: long-term follow-up.

Imre Szerb1, Laszlo Hangody, Zsofia Duska, Novak Pal Kaposi.   

Abstract

The successful treatment of chondral and osteochondral defects of the weightbearing surfaces is a challenge for orthopaedic surgeons. Autologous osteochondral transplantation is one method that can be used to create a hyaline or hyaline-like repair in the defect area. Ten years of clinical experience with autologous osteochondral mosaicplasty are described. Clinical scores, imaging techniques, arthroscopy, histological examination of biopsy samples, and cartilage stiffness measurements were used to evaluate the clinical outcomes and quality of the transplanted cartilage in a total of 831 patients who underwent mosaicplasty. According to our investigations, good-to-excellent results were achieved in 92% of the patients treated with femoral condylar implantations, in 87% of those treated with tibial resurfacing, in 79% of those treated with patellar and/or trochlear mosaicplasties, and in 94% of those treated with talarprocedures. Long-term donor-site disturbances, which were assessed using the Bandi score, showed that patients had 3% morbidity after mosaicplasty. Sixty-nine of 83 patients who were followed arthroscopically showed congruent gliding surfaces, histological evidence of the survival of the transplanted hyaline cartilage, and fibrocartilage filling of the donor sites. Four deep infections and 36 painful postoperative hemarthroses were experienced as complications arising from the surgical procedures. On the basis of both these promising results and also those of other similar studies, autologous osteochondral mosaicplasty would appears to be an alternative for the treatment of small and medium-sized focal chondral and osteochondral defects of the weightbearing surfaces of the knee and other weightbearing synovial joints.

Entities:  

Mesh:

Year:  2005        PMID: 16536220

Source DB:  PubMed          Journal:  Bull Hosp Jt Dis        ISSN: 0018-5647


  16 in total

1.  The Scaffold-Articular Cartilage Interface: A Combined In Vitro and In Silico Analysis Under Controlled Loading Conditions.

Authors:  Tony Chen; Moira M McCarthy; Hongqiang Guo; Russell Warren; Suzanne A Maher
Journal:  J Biomech Eng       Date:  2018-09-01       Impact factor: 2.097

2.  Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis.

Authors:  Toshihiro Nagai; Masato Sato; Miyuki Kobayashi; Munetaka Yokoyama; Yoshiki Tani; Joji Mochida
Journal:  Arthritis Res Ther       Date:  2014-09-18       Impact factor: 5.156

Review 3.  Silk constructs for delivery of musculoskeletal therapeutics.

Authors:  Lorenz Meinel; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2012-04-13       Impact factor: 15.470

Review 4.  MR imaging of cartilage and its repair in the knee--a review.

Authors:  S Trattnig; S Domayer; G W Welsch; T Mosher; F Eckstein
Journal:  Eur Radiol       Date:  2009-03-13       Impact factor: 5.315

5.  Nondestructive evaluation of a new hydrolytically degradable and photo-clickable PEG hydrogel for cartilage tissue engineering.

Authors:  Alexander J Neumann; Timothy Quinn; Stephanie J Bryant
Journal:  Acta Biomater       Date:  2016-05-11       Impact factor: 8.947

6.  Results of chondrocyte implantation with a fibrin-hyaluronan matrix: a preliminary study.

Authors:  S Nehrer; C Chiari; S Domayer; H Barkay; A Yayon
Journal:  Clin Orthop Relat Res       Date:  2008-06-05       Impact factor: 4.176

7.  Treatment of osteochondral defects in the rabbit's knee joint by implantation of allogeneic mesenchymal stem cells in fibrin clots.

Authors:  Markus T Berninger; Gabriele Wexel; Ernst J Rummeny; Andreas B Imhoff; Martina Anton; Tobias D Henning; Stephan Vogt
Journal:  J Vis Exp       Date:  2013-05-21       Impact factor: 1.355

Review 8.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

9.  Cartilage repair: A review of Stanmore experience in the treatment of osteochondral defects in the knee with various surgical techniques.

Authors:  S Vijayan; G Bentley; Twr Briggs; Ja Skinner; Rwj Carrington; R Pollock; Am Flanagan
Journal:  Indian J Orthop       Date:  2010-07       Impact factor: 1.251

10.  Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair.

Authors:  Toshihiro Nagai; Masato Sato; Toshiharu Kutsuna; Mami Kokubo; Goro Ebihara; Naoshi Ohta; Joji Mochida
Journal:  Arthritis Res Ther       Date:  2010-09-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.